University Hospital of North Norway - Paediatric
Welcome,         Profile    Billing    Logout  
 1 Trial 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Boye, Kjetil
MOTION, NCT05059262 / 2020-004883-25: Study of Vimseltinib for Tenosynovial Giant Cell Tumor

Active, not recruiting
3
120
Europe, Canada, US, RoW
vimseltinib, DCC-3014, Placebo
Deciphera Pharmaceuticals LLC, Deciphera Pharmaceuticals, LLC
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor, Diffuse, Tenosynovial Giant Cell Tumor, Localized
08/23
07/26
PERELI, NCT06389799: A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma

Recruiting
2
33
Europe
Pemigatinib, Retifanlimab
Lund University Hospital
Dedifferentiated Liposarcoma
12/27
12/28
NCT04776525: Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma

Recruiting
2
49
Europe
Ifosfamide, Holoxan, Doxorubicin, Adriamycin
Oslo University Hospital, Haukeland University Hospital
Soft Tissue Sarcoma
09/26
09/36
PROPANE, NCT05961761: Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients

Recruiting
2
80
Europe
Propranolol, Betablocker, Pembrolizumab, anti PD-1
Niels Junker, Aarhus University Hospital, Oslo University Hospital, Karolinska University Hospital
Soft Tissue Sarcoma Adult, Angiosarcoma, Undifferentiated Pleomorphic Sarcoma
01/28
12/28
FaR-RMS, NCT04625907 / 2018-000515-24: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

Recruiting
1/2
1672
Europe, RoW
Irinotecan, Actinomycin D, Dactinomycin, Doxorubicin, Ifosfamide, Vincristine, Vinorelbine, Cyclophosphamide, Temozolomide, radiotherapy, Regorafenib
University of Birmingham
Rhabdomyosarcoma
06/30
06/30
Nystad, Tove Anita
FaR-RMS, NCT04625907 / 2018-000515-24: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

Recruiting
1/2
1672
Europe, RoW
Irinotecan, Actinomycin D, Dactinomycin, Doxorubicin, Ifosfamide, Vincristine, Vinorelbine, Cyclophosphamide, Temozolomide, radiotherapy, Regorafenib
University of Birmingham
Rhabdomyosarcoma
06/30
06/30

Download Options